WHO aims for faster approval of variations to pre-qualified products
This article was originally published in Scrip
Executive Summary
The World Health Organization is looking at ways to improve, and speed up, the approval of variations applications submitted under its pre-qualification programme. This programme facilitates access to medicines that meet unified standards of quality, safety and efficacy of medicines.